General MedicationsINJECTIONStandard
TACROLIMUS
TACROLIMUS
Standard Dose
EQ 5MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TACROLIMUS is listed in Drugs@FDA under application 217108 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TACROLIMUS Form and strength INJECTABLE;INJECTION - EQ 5MG BASE/ML Sponsor NEXUS Submission history Latest submission status date: 2025-02-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview TACROLIMUS is listed in Drugs@FDA under application 217108 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TACROLIMUS Form and strength INJECTABLE;INJECTION - EQ 5MG BASE/ML Sponsor NEXUS Submission history Latest submission status date: 2025-02-12 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.